Vident Investment Advisory, LLC Atara Biotherapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $351,018 - $736,464	-74,844 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $103,702 - $207,527	12,287 Added 19.64%	74,844 $695,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $570,345 - $771,712	-38,799 Reduced 38.28%	62,557 $986,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $86,807 - $129,595	-7,240 Reduced 6.67%	101,356 $1.81 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $526,427 - $677,127	40,840 Added 60.28%	108,596 $1.69 Million

Q1 2021 May 14, 2021	SELL	$14.0 - $20.72 $4,760 - $7,044	-340 Reduced 0.5%	67,756 $973,000
Q4 2020 Feb 08, 2021	BUY	$12.67 - $26.23 $862,776 - $1.79 Million	68,096 New	68,096 $1.34 Million
Q2 2020 Jul 17, 2020	SELL	$7.53 - $14.93 $689,424 - $1.37 Million	-91,557 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$5.69 - $17.78 $32,524 - $101,630	-5,716 Reduced 5.88%	91,557 $779,000
Q4 2019 Feb 11, 2020	BUY	$10.89 - $16.79 $361,656 - $557,595	33,210 Added 51.84%	97,273 $1.6 Million
Q3 2019 Nov 13, 2019	SELL	$12.03 - $19.94 $22,014 - $36,490	-1,830 Reduced 2.78%	64,063 $905,000
Q2 2019 Aug 12, 2019	BUY	$19.05 - $41.04 $564,603 - $1.22 Million	29,638 Added 81.75%	65,893 $1.33 Million
Q1 2019 May 08, 2019	SELL	$28.4 - $41.74 $27,093 - $39,819	-954 Reduced 2.56%	36,255 $1.44 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $441,591 - $614,084	-14,291 Reduced 27.75%	37,209 $1.29 Million
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $120,291 - $149,292	-3,432 Reduced 6.25%	51,500 $2.13 Million
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $2.21 Million - $3.24 Million	-62,880 Reduced 53.37%	54,932 $2.02 Million
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $576,036 - $1.55 Million	32,002 Added 37.29%	117,812 $4.56 Million
Q4 2017 Feb 15, 2018	SELL	$13.2 - $18.1 $100,570 - $137,903	-7,619 Reduced 8.15%	85,810 $1.55 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $1.24 Million - $1.59 Million	93,429	93,429 $1.55 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account